Page 292 - SAMRC Annual Report 2023-24

ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
NOTES TO THE ANNUAL FINANCIAL STATEMENTS

(CONTINUED)

31 MARCH 31 MARCH
2024 2023
R R
36. Related parties (continued)

Related party balances
Loan accounts – Owing (to) by related parties
Medres (Pty) Ltd (The loan is not considered to be recoverable and has been written off.) 234,630 234,630

Amounts included in Trade receivable (Trade Payable) regarding related parties
National Health Laboratory Services (NHLS) (469) (150,000)
Dept. of Health (DOH) – 7,000,000
South African Health Products Regulatory Authority (SAHPRA) 39,890 –

Deferred Income (grants received in advance)
Dept. of Health (DOH) 1,382,812 5,716,884

Revenue – grants received and services rendered to related parties
Dept. of Health (DOH, revenue from non-exchange) 660,413,043 677,264,348
Dept. of Health (DOH) Contracts, revenue from exchange 584,348 6,679,130
National Health Laboratory Services 6,087 142,399
South African Health Products Regulatory Authority (SAHPRA) refund of unspent funds 39,890 133,900
661,043,368 684,219,777

Expenditure such as grants awarded, extra-mural unit grants and collaborative research
grants incurred with related party suppliers.
Repayment of unspent grant funds.
Dept. of Health (DOH) repayment of unspent grant 275,008 –
National Health Laboratory Services (NHLS) 160,469 523,000
South African Health Products Regulatory Authority (SAHPRA) 151,000 705,080
586,477 1,228,080
Executive authority information
Minister: Dr. MJ Phaahla
No subsistence, travel and other related re-imbursement costs have been paid.
Director General: Dr. S Buthelezi
No subsistence, travel and other related re-imbursement costs have been paid.

Executive Directors leave balances
Ms. V Bam 152,768 128,160
Mr. N Buick – 109,024
Prof. G Gray 237,720 223,973
Mr. M Popo 83,671 6,064
Dr. A Mathee 183,917 118,158
Dr. M Mdhluli 346,852 231,999
Dr. M Mulder 105,472 132,497
Mr. S Ngqongwa 68,409 –
Prof. L Zuhlke 133,747 73,507
1,312,556 1,023,382

290 SAMRC ANNUAL REPOR T 2023-24